Stonepine Capital Management, LLC, 10% Owner at Recro Pharma, Inc. (REPH), sold 260,276 shares at $7.69 ($2.0M) on 2017-05-04, disclosed to the SEC on 2017-05-05.
Open-market sale of $2.0M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.79 | 2,340 | $18K | 0.9% |
| 2 | $7.79 | 13,808 | $108K | 5.4% |
| 3 | $7.79 | 13,808 | $108K | 5.4% |
| 4 | $7.69 | 29,160 | $224K | 11.2% |
| 5 | $7.69 | 29,160 | $224K | 11.2% |
| 6 | $7.69 | 172,000 |
| $1.3M |
| 66.0% |
| Total | $7.70 avg | 260,276 | $2.0M | 100% |
| Filing → |